NEW YORK (GenomeWeb News) – BioTrove has named imaGenes as an OpenArray Service Provider, the first such designation for a firm outside of the US, imaGenes said today.
The Berlin-based genomics services provider will offer applications such as gene expression profiling, microRNA profiling analyses, and biomarker studies on the real-time qPCR platform. The OpenArray can run 9,000 assays simultaneously and enables one person to generate more than 27,000 assays in a single day.
"We chose imaGenes for their extensive experience in microarray and next generation sequencing services," Derek Potter, BioTrove's european director, said in a statement.
Financial and other terms of the agreement were not disclosed.